跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METRONIDAZOL MONTVEL 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
METRONIDAZOL MONTVEL 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
METRONIDAZOL MONTVEL 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Vegal Farmaceutica S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2021
Approval ID
326727449fff9394
Company
Vegal Farmaceutica S.L.
Type
Standard
Approval Details
Approval Id
326727449fff9394
Drug Cima Aemps Name
METRONIDAZOL MONTVEL 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85883
Holder Company Name
Vegal Farmaceutica S.L.
Marketing Company Name
Vegal Farmaceutica S.L.
Authorization Date
2021-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Vegal Farmaceutica S.L.
Active Ingredients
METRONIDAZOL
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2021
Approval ID
326727449fff9394
Type
Standard
Back to CIMA-AEMPS Approvals